Uniwersyteckie Centrum Kliniczne (Uck)

Gdansk 80-952

4 studies enrolling now · 6 studies all time

What they study most

Acute Myocardial Infarction (AMI), Adult Acute Myeloid Leukemia, Cardiovascular Risk, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Essential Thrombocythemia, Primary Immunodeficiency Diseases (PID)

Studies at this site

• A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia — Recruiting now
• Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT — Recruiting now
• A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes — Recruiting now
• ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack — Recruiting now
• A Study About the Long-Term Safety of TAK-881 in People With Primary Immunodeficiency Diseases — Running, not enrolling
• A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Insulin Icodec — Completed